Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis. - Wikidata - awgldk - TriplyDB

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

http://www.wikidata.org/entity/Q33723150

about

Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity Use of injectable spasticity management agents in a cancer center.Randomized, placebo-controlled trial of incobotulinumtoxina for upper-limb post-stroke spasticity A literature review on the efficacy and safety of botulinum toxin: an injection in post-stroke spasticity.Therapeutic use of botulinum toxin in neurorehabilitation.Patient Registry of Spasticity Care World: Data Analysis Based on Physician Experience.A Highly Specific Monoclonal Antibody for Botulinum Neurotoxin Type A-Cleaved SNAP25.Post-stroke Upper Limb Spasticity Incidence for Different Cerebral Infarction Site.

P2860

Q26750450-0BABCAD4-E187-441B-9CBB-0EA16F7A8B56 Q36650988-4139E6BE-771A-4632-BDAB-DBED305A28CA Q37340491-380AA27D-BDD2-45EB-9EE6-6F0C45C78BA7 Q38115299-31123857-BA7B-43E0-B2CD-E5459BBFBBF2 Q38414925-EE706101-469F-4B9E-AE8E-2234545566A8 Q38704938-3F0AEA28-552B-4620-AF10-2EA4A27DB7A4 Q42396665-1A01D56C-5F67-4336-BB72-5A2EC18224BA Q55019440-2BF003A0-4B2C-417A-8149-1EAD94046C9A

P2860

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

http://www.wikidata.org/entity/Q33723150

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

@ast

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

@en

type

label

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

@ast

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

@en

prefLabel

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

@ast

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

@en

P1433

Q33723150-68C4A963-69BB-48E1-9876-73B477DF5631

P1476

Q33723150-E559ECDC-E5D5-477F-80E3-0F634481A6E3

P2093

Q33723150-0F872DB3-3B22-45F2-B85D-377CB99892D5

Q33723150-1B3E8032-CBF9-4D7F-AF13-B1E1747BB62D

Q33723150-4A3FC160-BA88-458C-9D5A-4869BA70CA23

Q33723150-53FBC6DD-6C60-448D-AF78-0C852162921A

Q33723150-7F857102-BEF8-40C1-AFFE-DB36914A7A26

Q33723150-7FC667D4-3962-4FA3-9C7B-A955E4A7F553

Q33723150-995EE278-CAAC-4FA9-BC4A-22010FD727E3

P2860

Q33723150-2B9E48EB-361A-4C1D-B86E-053B5020B050

Q33723150-37574BC2-3678-46E6-B830-9F8AE4D86BAB

Q33723150-596E083C-AA02-423D-A32A-C962A3B88943

Q33723150-7E5ADD2C-3B43-4547-8562-8373958A90AA

Q33723150-A1720891-CEEB-4407-92B7-62033DFCCB2A

Q33723150-D2F4F757-CA48-43F0-AD89-D030D33D0413

Q33723150-D9FBEC81-02FC-42C3-B3CE-CAE7AB6F6E16

Q33723150-ECD02331-606A-4168-A6B4-C8BC7728C449

Q33723150-ECFAE970-279E-465F-967D-E396150DFF56

Q33723150-EE63199A-8EA7-4ED3-8C81-622331810B95

P304

Q33723150-EBF609CC-00FA-4C73-A074-C2B30DE92213

P31

Q33723150-8F209D87-FA05-4FAD-A35D-BC31581D2A62

P356

Q33723150-36F75AE6-9F76-499C-8E61-C8DDD358E3E1

P407

Q33723150-65C2CA55-13B0-4312-AD8E-BA9532DF0164

P433

Q33723150-B4B5EBAD-26EC-4952-BF4A-DE465155EF87

P478

Q33723150-896AED12-D83D-4318-955D-57C9C3C81A34

P577

Q33723150-1088864C-7141-46A1-B0EC-D6F1162584CD

P698

Q33723150-94106EF1-F166-41E8-B1C4-4DE7E891CA41

P921

Q33723150-1C17D024-9198-432C-B491-4B622F844365

P356

P1433

Movement Disorders

P1476

Dose response with onabotulinumtoxinA for post-stroke spasticity: a pooled data analysis.

@en

P2093

Amanda M VanDenburgh

http://www.w3.org/2001/XMLSchema#string

Frederick C Beddingfield

http://www.w3.org/2001/XMLSchema#string

Jihao Zhou

http://www.w3.org/2001/XMLSchema#string

Mitchell F Brin

http://www.w3.org/2001/XMLSchema#string

Stuart A Yablon

http://www.w3.org/2001/XMLSchema#string

Susan Abu-Shakra

http://www.w3.org/2001/XMLSchema#string

Susan M Garabedian-Ruffalo

http://www.w3.org/2001/XMLSchema#string

P2860

European consensus table on the use of botulinum toxin type A in adult spasticity.

Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.

Structural and functional changes in spastic skeletal muscle.

Instrumented assessment of muscle overactivity and spasticity with dynamic polyelectromyographic and motion analysis for treatment planning.

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review.

Clinical management of spasticity.

Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.

Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.

Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.

P304

209-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.23426

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20960474

http://www.w3.org/2001/XMLSchema#string

P921